Overview

  • Product name

    Cathepsin E Inhibitor Assay Kit (Fluorometric)
    See all Cathepsin E kits
  • Detection method

    Fluorescent
  • Sample type

    Inhibitor compounds
  • Assay type

    Quantitative
  • Product overview

    Cathepsin E Inhibitor Screening Kit (Fluorometric) (ab211082) provides a rapid, simple, sensitive and reliable test suitable for high-throughput screening of Cathepsin E inhibitors. It is based on the ability of an active Cathepsin E to cleave a synthetic MCA-based peptide substrate to release free MCA, which can be easily quantified using a fluorescence microplate reader. at Ex/Em = 320/420 nm. In the presence of a Cathepsin E specific inhibitor, cleavage of the substrate is reduced or abolish, resulting in decrease or total loss of MCA fluorescence.


    This simple and high-throughput adaptable assay kit can be used to screen, study or characterize potential inhibitors of Cathepsin E.


     

  • Notes

    Cathepsin E (CTSE, EC: 3.4.23.34) is a gastric aspartyl protease that functions as a disulfide-linked homodimer. This protease has a specificity similar to that of pepsin A and cathepsin D. It is an intracellular proteinase that is found in highest concentration on the surface of epithelial mucus-producing cells of the stomach. It is the first aspartic proteinase expressed in the fetal stomach and is found in more than half of gastric cancers.

  • Platform

    Microplate reader

Properties

  • Storage instructions

    Store at -20°C. Please refer to protocols.
  • Components 100 tests
    CTSE Assay Buffer 1 x 25ml
    CTSE Inhibitor (1 mM Pepstatin A in DMSO) 1 x 20µl
    CTSE Substrate 1 x 200µl
    Human Cathepsin E (500 µg) 1 vial
  • Research areas

  • Function

    May have a role in immune function. Probably involved in the processing of antigenic peptides during MHC class II-mediated antigen presentation. May play a role in activation-induced lymphocyte depletion in the thymus, and in neuronal degeneration and glial cell activation in the brain.
  • Tissue specificity

    Expressed abundantly in the stomach, the Clara cells of the lung and activated B-lymphocytes, and at lower levels in lymph nodes, skin and spleen. Not expressed in resting B-lymphocytes.
  • Sequence similarities

    Belongs to the peptidase A1 family.
  • Post-translational
    modifications

    Glycosylated. The nature of the carbohydrate chain varies between cell types. In fibroblasts, the proenzyme contains a high mannose-type oligosaccharide, while the mature enzyme contains a complex-type oligosaccharide. In erythrocyte membranes, both the proenzyme and mature enzyme contain a complex-type oligosaccharide.
    Two forms are produced by autocatalytic cleavage, form I begins at Ile-54, form II begins at Thr-57.
  • Cellular localization

    Endosome. The proenzyme is localized to the endoplasmic reticulum and Golgi apparatus, while the mature enzyme is localized to the endosome.
  • Information by UniProt
  • Alternative names

    • CATE
    • CATE_HUMAN
    • Cathepsin E
    • Cathepsin E form II
    • CTSE
    • Erythrocyte membrane aspartic proteinase
    • Slow moving proteinase
    see all

Associated products

Images

  • Typical inhibition curve of Cathepsin E activity by Pepstatin A (CTSE inhibitor). Assay was performed following the kit protocol.

Protocols

References

ab211082 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab211082.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up